{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:16:41Z","timestamp":1789514201151,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["UMO-2022\/45\/B\/NZ6\/01149"],"award-info":[{"award-number":["UMO-2022\/45\/B\/NZ6\/01149"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001115","name":"Foster Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006190","name":"Politechnika Gda\u0144ska","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118174","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:22:12Z","timestamp":1758576132000},"page":"118174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Bisacridine derivatives as effective eukaryotic topoisomerase II inhibitors"],"prefix":"10.1016","volume":"301","author":[{"given":"Kavya","family":"Kondaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrahmanyam","family":"Sappati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Rz\u0105d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Paluszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Maciejewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-7515","authenticated-orcid":false,"given":"Maciej","family":"Baginski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118174_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molstruc.2017.05.042","article-title":"Chemical structures and biological activities of bis- and tetrakis-acridine derivatives: a review","volume":"1146","author":"Nowak","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118174_bib2","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bcp.2007.02.016","article-title":"Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome","volume":"73","author":"Visp\u00e9","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118174_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00044-010-9321-6","article-title":"Synthesis and antimicrobial activities of novel bisacridine-1,8-dione derivatives","volume":"20","author":"Kaya","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118174_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127815","article-title":"A new 1-nitro-9-aminoacridine derivative targeting yeast topoisomerase II able to overcome fluconazole-resistance","volume":"35","author":"Rz\u0105d","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118174_bib5","first-page":"159","article-title":"DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage","volume":"9","author":"Holm","year":"1989","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118174_bib6","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1073\/pnas.81.9.2616","article-title":"DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication","volume":"81","author":"DiNardo","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2025.118174_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112599","article-title":"Design, synthesis and high antitumor potential of new unsymmetrical bisacridine derivatives towards human solid tumors, specifically pancreatic cancers and their unique ability to stabilize DNA G-quadruplexes","volume":"204","author":"Paluszkiewicz","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118174_bib8","series-title":"9-Alkilamino-1-nitroacridine Derivatives, US Patent 0105199","author":"Konopa","year":"1981"},{"key":"10.1016\/j.ejmech.2025.118174_bib9","first-page":"317","article-title":"Research on tumor-inhibiting compounds. Part LXXVI. Reactions of 1-nitro-9-aminoacridine derivatives with nucleophiles","volume":"60","author":"Wysocka-Skrzela","year":"1986","journal-title":"Pol. J. Chem."},{"key":"10.1016\/j.ejmech.2025.118174_bib10","first-page":"237","article-title":"Ledakrin - anticancerous medicine 1-nitro-9-(3-dimethylaminopropyloamino)-acridine-2HCl-H2O","volume":"8","author":"Led\u00f3chowski","year":"1976","journal-title":"Mater. Med. Pol."},{"key":"10.1016\/j.ejmech.2025.118174_bib11","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2388","article-title":"Structure of a topoisomerase II-DNA-nucleotide complex reveals a new control mechanism for ATPase activity","volume":"19","author":"Schmidt","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118174_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jmb.2012.07.014","article-title":"The structure of DNA-bound human topoisomerase II\u03b1: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage","volume":"424","author":"Wendorff","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118174_bib13","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1128\/AAC.36.12.2778","article-title":"DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs","volume":"36","author":"Shen","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118174_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-4781(98)00134-1","article-title":"Clinical applications of anticancer drugs targeted to topoisomerase II","volume":"1400","author":"Hande","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2025.118174_bib15","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1074\/jbc.M117.810580","article-title":"Resveratrol: a novel type of topoisomerase II inhibitor","volume":"292","author":"Lee","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118174_bib16","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1021\/bi201159b","article-title":"Amsacrine as a topoisomerase II poison: importance of drug-DNA interactions","volume":"51","author":"Ketron","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118174_bib17","series-title":"Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved standard\u2014third Edition, CLSI Document M27-A3","year":"2008"},{"key":"10.1016\/j.ejmech.2025.118174_bib18","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1128\/AAC.42.12.3065","article-title":"Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains","volume":"42","author":"Franz","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118174_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1046\/j.1439-0507.1999.00498.x","article-title":"Molecular aspects of fluconazole resistance development in Candida albicans","volume":"42","author":"Franz","year":"1999","journal-title":"Mycoses"},{"key":"10.1016\/j.ejmech.2025.118174_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1099\/jmm.0.000062","article-title":"Mechanisms of azole resistance among clinical isolates of Candida glabrata in Poland","volume":"64","author":"Szweda","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ejmech.2025.118174_bib21","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1128\/EC.2.6.1361-1375.2003","article-title":"Functional characterization of Candida albicans ABC transporter Cdr1p","volume":"2","author":"Shukla","year":"2003","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ejmech.2025.118174_bib22","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/AAC.01497-08","article-title":"Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals","volume":"53","author":"Sharma","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118174_bib23","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1128\/AAC.45.12.3366-3374.2001","article-title":"Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters","volume":"45","author":"Nakamura","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.118174_bib24","doi-asserted-by":"crossref","first-page":"9311","DOI":"10.1038\/s41598-025-93863-z","article-title":"Anticancer drugs targeting topoisomerase II for antifungal treatment","volume":"15","author":"Kondaka","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118174_bib25","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/EC.00315-06","article-title":"Structure and function analysis of CaMdr1p, a major facilitator superfamily antifungal efflux transporter protein of Candida albicans: identification of amino acid residues critical for drug\/H+ transport","volume":"6","author":"Pasrija","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ejmech.2025.118174_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-54252-0","article-title":"Targeting yeast topoisomerase II by imidazo and triazoloacridinone derivatives resulting in their antifungal activity","volume":"14","author":"Rz\u0105d","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118174_bib27","series-title":"Gaussian 16, Revision C.01","author":"Frisch","year":"2016"},{"key":"10.1016\/j.ejmech.2025.118174_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Parr","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.ejmech.2025.118174_bib29","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","article-title":"Density\u2010functional thermochemistry. III. The role of exact exchange","volume":"98","author":"Becke","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118174_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cplett.2004.06.011","article-title":"A new hybrid exchange\u2013correlation functional using the Coulomb-attenuating method (CAM-B3LYP)","volume":"393","author":"Yanai","year":"2004","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.ejmech.2025.118174_bib31","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1039\/b810189b","article-title":"Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections","volume":"10","author":"Chai","year":"2008","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ejmech.2025.118174_bib32","series-title":"Chemical Computing Group ULC","article-title":"Version 2024.0601","year":"2024"},{"key":"10.1016\/j.ejmech.2025.118174_bib33","doi-asserted-by":"crossref","first-page":"9467","DOI":"10.1038\/s41598-025-93122-1","article-title":"Structural insights into fungal and human topoisomerase II with implications for in silico antifungal drug design","volume":"15","author":"Sappati","year":"2025","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:08:26Z","timestamp":1773130106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"alternative-id":["S0223523425009390"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118174","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bisacridine derivatives as effective eukaryotic topoisomerase II inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118174"}}